Goldman Sachs Group »

Spero Therapeutics shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Spero Therapeutics (SPRO) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Spero Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Spero Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Spero Therapeutics by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2026-06-30 $568k 257k 2.21
2022-06-30 $225k 303k 0.74
2022-03-31 $1.2M 141k 8.70
2021-12-31 $2.2M 139k 16.01
2021-09-30 $2.5M 138k 18.41
2021-03-31 $3.8M 256k 14.72
2020-12-31 $808k 42k 19.40
2020-09-30 $350k 31k 11.16
2020-06-30 $703k 52k 13.53
2019-12-31 $303k 32k 9.61
2019-09-30 $146k 14k 10.58
2019-06-30 $253k 22k 11.51
2019-03-31 $163k 13k 12.84
2018-12-31 $100k 16k 6.17